TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 22 filers reported holding TRINITY BIOTECH PLC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,036 | -22.7% | 409,517 | 0.0% | 0.16% | -56.8% |
| Q2 2023 | $389,492 | +1.2% | 409,517 | 0.0% | 0.37% | +2.2% |
| Q1 2023 | $384,946 | -5.1% | 409,517 | 0.0% | 0.36% | +13.7% |
| Q4 2022 | $405,422 | -7.6% | 409,517 | 0.0% | 0.32% | -35.5% |
| Q3 2022 | $439,000 | -12.5% | 409,517 | 0.0% | 0.49% | -22.0% |
| Q2 2022 | $502,000 | +15.7% | 409,517 | 0.0% | 0.63% | +53.4% |
| Q1 2022 | $434,000 | +768.0% | 409,517 | +1067.8% | 0.41% | +920.0% |
| Q4 2021 | $50,000 | – | 35,068 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |